DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Reck M, Mellemgaard A, von Pawel J. et al.
Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel.
Lung Cancer 2015;
90: 267-273
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.